Rare diseases
Investigational molecules
Locations
Study on the Safety and Tolerability of Elexacaftor, Tezacaftor, and Ivacaftor in Children with Cystic Fibrosis Aged 12 to Less Than 24 Months
DenmarkStudy on Liraglutide for Weight Management in Children Aged 6 to 12 with Obesity
BelgiumStudy on Switching from Boosted Protease Inhibitors to Fostemsavir for People with HIV-1 with Limited Treatment Options
ItalyStudy Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
AustriaStudy on Patient Preference for Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Melanoma, Renal Cell Carcinoma, and Lung Cancer Patients
FranceStudy on Bepirovirsen for Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue Treatment
BulgariaStudy Comparing Abatacept and Adalimumab for Adults with Early Rheumatoid Arthritis Not Responding to Methotrexate
CzechiaStudy of TAK-280, Tocilizumab, and Siltuximab for Patients with Advanced or Metastatic Cancer
FranceStudy of RO7247669 at Different Doses for People with Previously Untreated Advanced Melanoma that Cannot be Removed by Surgery or Has Spread
CzechiaStudy on Ixekizumab for Rapid Pain Relief in Patients with Axial Spondyloarthritis
GermanyStudy on the Effects of Ribitol (BBP-418) in Patients with Limb Girdle Muscular Dystrophy Type 2I
DenmarkStudy Comparing 177Lu-PSMA-617 with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
